These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20112383)

  • 1. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
    Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
    Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
    Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
    Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
    Hammad A; Mossad YM; Nasef N; Eid R
    Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis.
    Liu HF; An XJ; Yang Y; Yang L; Li Y; Huang CZ; Tao J; Tu YT
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):15-21. PubMed ID: 23392701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.
    Stone RC; Du P; Feng D; Dhawan K; Rönnblom L; Eloranta ML; Donnelly R; Barnes BJ
    PLoS One; 2013; 8(1):e54487. PubMed ID: 23349905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.
    Miceli-Richard C; Comets E; Loiseau P; Puechal X; Hachulla E; Mariette X
    Arthritis Rheum; 2007 Dec; 56(12):3989-94. PubMed ID: 18050197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
    Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
    Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.
    Alonso-Perez E; Suarez-Gestal M; Calaza M; Kwan T; Majewski J; Gomez-Reino JJ; Gonzalez A
    Arthritis Res Ther; 2011 May; 13(3):R80. PubMed ID: 21627826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.
    Kawasaki A; Kyogoku C; Ohashi J; Miyashita R; Hikami K; Kusaoi M; Tokunaga K; Takasaki Y; Hashimoto H; Behrens TW; Tsuchiya N
    Arthritis Rheum; 2008 Mar; 58(3):826-34. PubMed ID: 18311811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.
    Carmona FD; Martin JE; Beretta L; Simeón CP; Carreira PE; Callejas JL; Fernández-Castro M; Sáez-Comet L; Beltrán E; Camps MT; Egurbide MV; ; Airó P; Scorza R; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Madhok R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Schuerwegh AJ; Vonk MC; Voskuyl AE; Radstake TR; Martín J
    PLoS One; 2013; 8(1):e54419. PubMed ID: 23372721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.
    Löfgren SE; Yin H; Delgado-Vega AM; Sanchez E; Lewén S; Pons-Estel BA; Witte T; D'Alfonso S; Ortego-Centeno N; Martin J; Alarcón-Riquelme ME; Kozyrev SV
    J Rheumatol; 2010 Mar; 37(3):574-8. PubMed ID: 20080916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation.
    Cunninghame Graham DS; Manku H; Wagner S; Reid J; Timms K; Gutin A; Lanchbury JS; Vyse TJ
    Hum Mol Genet; 2007 Mar; 16(6):579-91. PubMed ID: 17189288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.